Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

General Meeting Statement

4 Jul 2023 07:00

RNS Number : 8237E
Versarien PLC
04 July 2023
 

 

 

4 July 2023

 

Versarien plc

 

("Versarien" or the "Company")

 

General Meeting Statement

 

Versarien plc (AIM: VRS), the advanced materials engineering group, will be holding a General Meeting at 10.00 a.m. today, at which the following statement will be provided:

 

"The Company's turnaround strategy continues to progress and we are pleased to provide an update:

 

Organisational Structure

 

The disposal of assets, including the mature businesses and the intellectual property and plant acquired from Hanwha Aerospace in Korea in 2020 continue to be marketed for sale and we have a number of interested parties, particularly in the intellectual property, who are reviewing information in the data rooms. However, the timing of any asset sales and the quantum of the funds that may be received is uncertain.

 

The Company's cost base has been reduced significantly in recent months with unaudited LBITDAE (loss before interest, tax, depreciation, amortisation and exceptional items) at a much lower level than in the first six months of the financial year.

 

The Company continues to focus on its two development and commercialisation areas:

 

CementeneTM

 

· Versarien Graphene Limited has been shortlisted by the Global Cement and Concrete Association ("GCCA"), from a global list of applications, for its pioneering Innovandi Open Challenge scheme, to work on developing low-carbon concrete. The shortlist drawn up by the GCCA and its member companies is intended to represent the most promising and deployable technologies.

 

Versarien's graphene materials have been supplied to its partners for use in a trial pour in the Netherlands using recycled construction materials, processed using renewable energies.

 

Following the announcement on 17 May 2023 further testing is planned with Banagher Precast Concrete and other UK and European concrete manufacturers. We remain confident of the commercial potential of our Cementene™ enhanced concrete.

 

Graphene-WearTM

 

Commercially we are continuing to supply the textile sector, including Umbro for their Autumn/Winter 2023 and Spring/Summer 2024 ranges. This has included the development of new Graphene-Wear™ formulations that also include colourants.

 

We have provided graphene enhanced thermoplastic polymer masterbatches to Umbro and other clients for sports equipment. Developments with graphene and hBN (hexagonal boron nitride) enhanced textile polymer masterbatches are also progressing, with a grant application submitted for the optimisation of 2d material enhanced extruded yarns with other UK partners.

 

In summary, the turnaround strategy, which focuses on a light manufacturing model, is continuing as planned and we look forward to updating shareholders on further progress in due course."

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended.

 

For further information please contact:

 

Versarien

Diane Savory, Non-executive Chair

Chris Leigh, Chief Financial Officer

Stephen Hodge, Chief Technology Officer

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien:

 

The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a light manufacturing and licensing model.

 

For further information please see: http://www.versarien.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
GMSUPUBUMUPWGMW
Date   Source Headline
9th Feb 20267:00 amRNSCancellation - Versarien Plc
6th Jan 20261:34 pmRNSAppointment of Administrators
19th Dec 20254:36 pmRNSUpdate on NOIA
19th Dec 20254:36 pmRNSUpdate on NOIA
15th Dec 20253:53 pmRNSUpdate on the Disposal of AAC Cyroma Limited
12th Dec 20257:00 amRNSUpdate on NOIA and Change of Registered Office
1st Dec 20257:30 amRNSSuspension - Versarien plc
1st Dec 20257:00 amRNSIntention to Appoint Administrators, Suspension
26th Nov 20257:00 amRNSUpdate - Proposed Disposal of the Company's Assets
31st Oct 20258:48 amRNSProposed Disposal of the Company’s Assets
29th Sep 20252:32 pmRNSCorporate Update
10th Sep 20251:00 pmRNSCorporate Update
29th Aug 20252:19 pmRNSCorporate Update
21st Aug 20257:00 amRNSStrategic Investment and Joint Venture Update
11th Aug 20257:00 amRNSCorporate Update
5th Aug 202511:03 amRNSHolding(s) in Company
29th Jul 20257:00 amRNSCorporate Update
22nd Jul 202510:55 amRNSSettlement of Legal Claims
4th Jul 20257:00 amRNS-RSouth American Polygrene™ Themoplastics Agreements
30th Jun 20253:03 pmRNSInterim Results
19th Jun 20252:34 pmRNSBuilding for Humanity – Contract Update
4th Jun 202511:49 amRNSHolding(s) in Company
2nd Jun 20252:03 pmRNSHolding(s) in Company
30th May 202510:19 amRNSHolding(s) in Company
30th May 20257:00 amRNSTotal Voting Rights
29th May 20253:29 pmRNSHolding(s) in Company
29th May 202510:20 amRNSHolding(s) in Company
27th May 202511:59 amRNSHolding(s) in Company
27th May 202511:02 amRNSHolding(s) in Company
23rd May 20259:38 amRNSHolding(s) in Company
22nd May 202511:56 amRNSHolding(s) in Company
21st May 202510:58 amRNSHolding(s) in Company
20th May 202511:11 amRNSHolding(s) in Company
14th May 20257:00 amRNSPlacing to raise £425,000
2nd May 202511:00 amRNSUpdate on Legal Claims
28th Apr 20251:04 pmRNSResult of AGM
27th Mar 20257:00 amRNSAudited Results for year ended 30 September 2024
24th Mar 202511:24 amRNSResult of General Meeting
10th Mar 20257:00 amRNS-RGraphinks™ supply agreement with Montana Química
5th Mar 20257:00 amRNSNotice of General Meeting
3rd Mar 20257:00 amRNSCompletion of Sale of Korean Assets
28th Feb 20257:00 amRNSTotal Voting Rights
27th Feb 20257:00 amRNSInnovate UK Loan Deed of Variation
10th Feb 20258:35 amRNSHolding(s) in Company
28th Jan 20252:36 pmRNSPlacing to raise £246k
30th Dec 202412:00 pmRNSUpdate on Sale of Korean Assets
13th Dec 20242:58 pmRNSHolding(s) in Company
13th Dec 202411:50 amRNSHolding(s) in Company
13th Dec 202410:11 amRNSHolding(s) in Company
13th Dec 20247:00 amRNS€804,000 Grant Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.